Published in Proc Natl Acad Sci U S A on November 12, 2012
Rare cell isolation and analysis in microfluidics. Lab Chip (2014) 1.42
Probing circulating tumor cells in microfluidics. Lab Chip (2013) 1.34
Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications. J Am Chem Soc (2013) 1.26
Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation. Lab Chip (2015) 1.09
RNAi-microsponges form through self-assembly of the organic and inorganic products of transcription. Small (2014) 1.09
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget (2014) 1.08
Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices. ACS Nano (2013) 1.05
Micro total analysis systems: fundamental advances and biological applications. Anal Chem (2013) 1.05
UV activation of polymeric high aspect ratio microstructures: ramifications in antibody surface loading for circulating tumor cell selection. Lab Chip (2014) 1.02
SpyLigase peptide-peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture. Proc Natl Acad Sci U S A (2014) 0.97
Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells. Adv Mater (2015) 0.91
DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. Theranostics (2015) 0.89
Towards XNA nanotechnology: new materials from synthetic genetic polymers. Trends Biotechnol (2014) 0.89
Effects of nanopillar array diameter and spacing on cancer cell capture and cell behaviors. Nanoscale (2014) 0.85
DNA Aptamer Technology for Personalized Medicine. Curr Opin Chem Eng (2014) 0.81
Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics (2016) 0.78
Biodegradable nano-films for capture and non-invasive release of circulating tumor cells. Biomaterials (2015) 0.78
Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cells. Chem Commun (Camb) (2015) 0.78
Ptk7 and Mcc, Unfancied Components in Non-Canonical Wnt Signaling and Cancer. Cancers (Basel) (2016) 0.77
Recent advances in nanotechnology-based detection and separation of circulating tumor cells. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.77
Perspective on microfluidic cell separation: a solved problem? Anal Chem (2014) 0.76
Microfluidic devices to enrich and isolate circulating tumor cells. Lab Chip (2015) 0.76
Selection of DNA nanoparticles with preferential binding to aggregated protein target. Nucleic Acids Res (2016) 0.75
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device. Sci Rep (2017) 0.75
Catch-and-Release of Target Cells Using Aptamer-Conjugated Electroactive Zwitterionic Oligopeptide SAM. Sci Rep (2017) 0.75
Facile supermolecular aptamer inhibitors of L-selectin. PLoS One (2015) 0.75
Engineering artificial machines from designable DNA materials for biomedical applications. Tissue Eng Part B Rev (2015) 0.75
Enrichment and single-cell analysis of circulating tumor cells. Chem Sci (2016) 0.75
Aptamers: versatile molecular recognition probes for cancer detection. Analyst (2016) 0.75
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Overstretching B-DNA: the elastic response of individual double-stranded and single-stranded DNA molecules. Science (1996) 18.53
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer (2008) 7.99
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A (2010) 7.77
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res (2007) 6.59
Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A (2006) 5.35
Rolling replication of short DNA circles. Proc Natl Acad Sci U S A (1995) 5.09
In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat Nanotechnol (2009) 3.21
Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew Chem Int Ed Engl (2011) 2.79
Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res (2010) 2.48
Stretching single stranded DNA, a model polyelectrolyte. Phys Rev Lett (2002) 1.90
Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew Chem Int Ed Engl (2009) 1.86
Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal Chem (2009) 1.78
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood (2002) 1.75
High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. Anal Chem (2011) 1.62
Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal Chem (2009) 1.61
Microsystems for the capture of low-abundance cells. Annu Rev Anal Chem (Palo Alto Calif) (2010) 1.50
Molecular assembly for high-performance bivalent nucleic acid inhibitor. Proc Natl Acad Sci U S A (2008) 1.44
Physicochemical effects of aldehydes on the human erythrocyte. J Cell Biol (1972) 1.37
Rolling circle amplification: applications in nanotechnology and biodetection with functional nucleic acids. Angew Chem Int Ed Engl (2008) 1.35
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood (1997) 1.33
Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. Cancer Res (2010) 1.26
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia. Nucleic Acids Res (2010) 1.22
The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. Blood (2010) 1.11
Aptamer-mediated efficient capture and release of T lymphocytes on nanostructured surfaces. Adv Mater (2011) 1.07
Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway. PLoS One (2010) 1.07
Controlled capture and release of cardiac fibroblasts using peptide-functionalized alginate gels in microfluidic channels. Lab Chip (2009) 1.04
Nanoporous elements in microfluidics for multiscale manipulation of bioparticles. Small (2011) 0.95
DNA polymerization on gold nanoparticles through rolling circle amplification: towards novel scaffolds for three-dimensional periodic nanoassemblies. Angew Chem Int Ed Engl (2006) 0.93
Increasing the complexity of periodic protein nanostructures by the rolling-circle-amplified synthesis of aptamers. Angew Chem Int Ed Engl (2008) 0.91
Cascade signal amplification for DNA detection. Chembiochem (2006) 0.91
Targeted cell-cell interactions by DNA nanoscaffold-templated multivalent bispecific aptamers. Small (2011) 0.88
Minimal residual disease studies in acute leukemia. Am J Clin Pathol (2004) 0.85
Nanoparticle coatings for enhanced capture of flowing cells in microtubes. ACS Nano (2010) 0.84
Polymerase chain reaction-based detection of minimal residual disease in acute lymphoblastic leukemia predicts relapse after allogeneic BMT. Biol Blood Marrow Transplant (1995) 0.78
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol (2003) 6.07
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity (2007) 4.49
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science (2009) 3.85
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80
Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell (2012) 3.33
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med (2010) 2.86
Thyroid hormone inactivation in gastrointestinal stromal tumors. N Engl J Med (2014) 2.80
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet (2012) 2.17
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A (2011) 2.16
A cell-laden microfluidic hydrogel. Lab Chip (2007) 2.15
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement. Am J Clin Pathol (2012) 1.99
Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip (2005) 1.89
Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc Natl Acad Sci U S A (2003) 1.85
New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell (2008) 1.82
Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett (2008) 1.80
Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials (2006) 1.79
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol (2002) 1.75
Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. Int J Cardiol (2011) 1.75
Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem (2009) 1.73
Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res (2011) 1.71
Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A (2010) 1.64
Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal Chem (2009) 1.61
Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab (2003) 1.58
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem (2008) 1.57
DNA translocation in inorganic nanotubes. Nano Lett (2005) 1.55
A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions. Cancer Prev Res (Phila) (2008) 1.53
Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma. Leuk Lymphoma (2012) 1.49
Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J Clin Invest (2006) 1.49
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond) (2007) 1.47
PICK1 deficiency causes male infertility in mice by disrupting acrosome formation. J Clin Invest (2009) 1.44
Engineered cell homing. Blood (2011) 1.43
Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases. Leuk Lymphoma (2014) 1.43
APC(Cdh1) mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity. Nat Neurosci (2010) 1.43
New frontiers in nanotechnology for cancer treatment. Urol Oncol (2008) 1.42
Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem (2007) 1.42
Automated flow cytometric analysis of blood cells in cerebrospinal fluid: analytic performance. Am J Clin Pathol (2004) 1.41
Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population. J Clin Hypertens (Greenwich) (2014) 1.41
Synthesis and characterization of photocurable elastomers from poly(glycerol-co-sebacate). Biomacromolecules (2007) 1.39
Retracted Association study of TGFBR2 and miR-518 gene polymorphisms with age at natural menopause, premature ovarian failure, and early menopause among Chinese Han women. Medicine (Baltimore) (2014) 1.39
Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A (2007) 1.39
Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol (2012) 1.39
Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci Transl Med (2013) 1.38
Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials (2005) 1.38
Physical manipulation of the Escherichia coli chromosome reveals its soft nature. Proc Natl Acad Sci U S A (2012) 1.35
Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano (2010) 1.35
Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv (2006) 1.35
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials (2009) 1.35
Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol (2010) 1.35
The effect of integration time on fluctuation measurements: calibrating an optical trap in the presence of motion blur. Opt Express (2006) 1.34
pH-Responsive nanoparticles for drug delivery. Mol Pharm (2010) 1.33
Microstructured barbs on the North American porcupine quill enable easy tissue penetration and difficult removal. Proc Natl Acad Sci U S A (2012) 1.32
Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol (2008) 1.32
PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance. PLoS Biol (2013) 1.31
Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther (2008) 1.30
Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. Proc Natl Acad Sci U S A (2013) 1.30
Cell-surface sensors for real-time probing of cellular environments. Nat Nanotechnol (2011) 1.28
Materials science: Dry solution to a sticky problem. Nature (2011) 1.28
Selective ionic transport through tunable subnanometer pores in single-layer graphene membranes. Nano Lett (2014) 1.25
Regulation of singlet oxygen generation using single-walled carbon nanotubes. J Am Chem Soc (2008) 1.23
Carbon nanotube membranes with ultrahigh specific adsorption capacity for water desalination and purification. Nat Commun (2013) 1.22
Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol (2006) 1.21
Reusable, reversibly sealable parylene membranes for cell and protein patterning. J Biomed Mater Res A (2008) 1.21
Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem (2009) 1.20
Clustering and synaptic targeting of PICK1 requires direct interaction between the PDZ domain and lipid membranes. EMBO J (2007) 1.20
Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. Biomaterials (2011) 1.20
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev (2012) 1.18
Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels. Adv Mater (2011) 1.17